| |||||||||
PHARSIGHT CORP 8-K 2007 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2007
PHARSIGHT CORPORATION (Exact name of registrant as specified in its charter)
321 E. Evelyn Ave. 3rd Floor Mountain View, CA 94041 (Address and zip code of principal executive offices) (650) 314-3800 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 3.02 Unregistered Sales of Equity Securities. On March 1, 2007, we issued as a dividend an aggregate of 18,142 unregistered shares of our Series B redeemable convertible preferred stock to four of our Series A redeemable convertible preferred stockholders. The holders of our Series A redeemable convertible preferred stock are entitled to receive an annual dividend at the rate of 8% of the original issue price of $4.008 on each outstanding share of Series A redeemable convertible preferred stock, which is payable quarterly in cash or shares of Series B redeemable convertible preferred stock at the election of the holder. We believe this transaction was exempt from the registration requirements of the Securities Act of 1933, as amended, in reliance on Section 4(2) thereof or Regulation D promulgated thereunder, as a transaction by an issuer not involving a public offering. Each share of Series B redeemable convertible preferred stock is convertible into four shares of our common stock at the election of the holder or upon the occurrence of certain other events described in our certificate of designations of Series A and Series B convertible preferred stock.
-2-
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 1, 2007
-3- | ||||||||||||||||||||||||||||||||||||||||||
